Cargando…

Timing of Bisphosphonate (Alendronate) Initiation after Surgery for Fragility Fracture: A Population-Based Cohort Study

Bisphosphonates are used as first-line treatment for the prevention of fragility fracture (FF); they act by inhibiting osteoclast-mediated bone resorption. The timing of their administration after FF surgery is controversial; thus, we compared the incidence of second FF, surgery for second FF, and a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Meng-Huang, Lin, Yu-Sheng, Wu, Christopher, Lee, Ching-Yu, Chen, Yi-Chia, Huang, Tsung-Jen, Cheng, Jur-Shan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229144/ https://www.ncbi.nlm.nih.gov/pubmed/34201202 http://dx.doi.org/10.3390/jcm10122541

Ejemplares similares

Effectiveness of bisphosphonates on nonvertebral and hip fractures in the first year of therapy: The risedronate and alendronate (REAL) cohort study
por: Silverman, S. L., et al.
Publicado: (2006)

Understanding fragility fracture patients’ decision-making process regarding bisphosphonate treatment
por: Wozniak, L. A., et al.
Publicado: (2016)

The bisphosphonates alendronate and zoledronate induce adaptations of aerobic metabolism in permanent human endothelial cells
por: Budzinska, Adrianna, et al.
Publicado: (2023)

Trends in Incidence of Subtrochanteric Fragility Fractures and Bisphosphonate Use Among the US Elderly, 1996–2007
por: Wang, Zhong, et al.
Publicado: (2011)

Lower incidence of fracture after IV bisphosphonates in girls with Rett syndrome and severe bone fragility
por: Lambert, Anne-Sophie, et al.
Publicado: (2017)

Assessing the Effectiveness of Bisphosphonates for the Prevention of Fragility Fractures: An Updated Systematic Review and Network Meta‐Analyses
por: Bastounis, Anastasios, et al.
Publicado: (2022)

Effects of alendronate sodium combined with InterTan on osteoporotic femoral intertrochanteric fractures and fracture recurrence
por: Wang, Ke-Meng, et al.
Publicado: (2022)

Application of microRNA in Human Osteoporosis and Fragility Fracture: A Systemic Review of Literatures
por: Wu, Yen-Zung, et al.
Publicado: (2021)

Longitudinal change in clinical fracture incidence after initiation of bisphosphonates
por: Abelson, A., et al.
Publicado: (2009)

Atypical fracture of the ulna associated with alendronate use
por: Bjørgul, Kristian, et al.
Publicado: (2011)

Effect of Sequential Treatment with Bisphosphonates After Teriparatide in Ovariectomized Rats: A Direct Comparison Between Risedronate and Alendronate
por: Yano, Tetsuo, et al.
Publicado: (2017)

Comparison of Risk of Osteoporotic Fracture in Denosumab vs Alendronate Treatment Within 3 Years of Initiation
por: Pedersen, Alma B., et al.
Publicado: (2019)

Meta-regression analysis of the efficacy of alendronate for prevention of glucocorticoid-induced fractures
por: Qiu, Mei, et al.
Publicado: (2020)

The Carcinogenicity of Alendronate in Patients with Osteoporosis: Evidence from Cohort Studies
por: Chen, Ling-Xiao, et al.
Publicado: (2015)

Discontinuation of alendronate and administration of bone-forming agents after surgical nailing may promote union of atypical femoral fractures in patients on long-term alendronate therapy
por: Lin, Tsung-Li, et al.
Publicado: (2013)

Commentary: Association Between Alendronate Use and Hip Fracture Risk in Older Patients Using Oral Prednisolone
por: Wu, Xiang-Dong, et al.
Publicado: (2017)

Incidence and predictors of fragility fracture in postmenopausal rheumatoid arthritis patients receiving oral bisphosphonates: a longitudinal observational study
por: Kishimoto, Yuji, et al.
Publicado: (2022)

Bisphosphonates and Their Connection to Dental Procedures: Exploring Bisphosphonate-Related Osteonecrosis of the Jaws
por: Lee, Emily Sunny, et al.
Publicado: (2023)

Perforation of gastric volvulus within a giant hiatus hernia secondary to alendronate: A rare complication of bisphosphonate use()
por: Kwan, Bianca, et al.
Publicado: (2020)

Association between alendronate and atypical femur fractures: a meta-analysis
por: Liu, Lu, et al.
Publicado: (2015)

Surgery for fragility hip fracture—streamlining the process
por: Leung, F., et al.
Publicado: (2010)

Comparing medication adherence in patients receiving bisphosphonates for preventing fragility fractures: a comprehensive systematic review and network meta-analysis
por: Bastounis, A., et al.
Publicado: (2022)

Timing of Bisphosphonate Initiation After Fracture: What Does the Data Really Say?
por: Barton, David W., et al.
Publicado: (2020)

Bisphosphonates and Atypical Fractures of Femur
por: Yli-Kyyny, Tero
Publicado: (2011)

Atypical femoral fractures and bisphosphonates
por: Jawad, Ali S. M.
Publicado: (2017)

High Expression of Acid-Sensing Ion Channel 2 (ASIC2) in Bone Cells in Osteoporotic Vertebral Fractures
por: Lee, Ching-Yu, et al.
Publicado: (2019)

Alendronate and Raloxifene Therapy in the Early Period after Hip Fracture
por: Ohishi, Tsuyoshi, et al.
Publicado: (2011)

Risk Factors for Spine Reoperation and Joint Replacement Surgeries after Short-Segment Lumbar Spinal Surgeries for Lumbar Degenerative Disc Disease: A Population-Based Cohort Study
por: Wu, Meng-Huang, et al.
Publicado: (2021)

Nickel alendronate
por: Sikorska, Małgorzata, et al.
Publicado: (2012)

Does timing of surgery matter in fragility hip fractures?
por: Leung, F., et al.
Publicado: (2010)

Efficient Transdermal Delivery of Alendronate, a Nitrogen-Containing Bisphosphonate, Using Tip-Loaded Self-Dissolving Microneedle Arrays for the Treatment of Osteoporosis
por: Katsumi, Hidemasa, et al.
Publicado: (2017)

A Case of Fragility Fracture of the Pelvis Initially Diagnosed as Osteoarthritis of the Hip
por: Ogawa, Ryo, et al.
Publicado: (2022)

Comparison of long-term outcomes of spinal fusion surgeries supplemented with “topping-off” implants in lumbar degenerative diseases: A systematic review and network meta-analysis()
por: Chiou, Katie, et al.
Publicado: (2022)

Cost-effectiveness of sequential daily teriparatide/weekly alendronate compared with alendronate monotherapy for older osteoporotic women with prior vertebral fracture in Japan
por: Mori, Takahiro, et al.
Publicado: (2021)

Risk of Contralateral Hip Fracture Following Initial Hip Fracture Among Geriatric Fragility Fracture Patients
por: Ratnasamy, Philip P., et al.
Publicado: (2023)

Primary Sjogren syndrome increases the risk of bisphosphonate-related osteonecrosis of the jaw
por: Kuo, Pei-I, et al.
Publicado: (2021)

Prevention of bisphosphonate-related mandibular fractures
por: Pedrazzoli, M., et al.
Publicado: (2016)

Bisphosphonates and atypical subtrochanteric fractures of the femur
por: Kharwadkar, N., et al.
Publicado: (2017)

Bisphosphonate-related Femoral Shaft Fracture
por: Kellar, Jesse, et al.
Publicado: (2019)

Bisphosphonate Use and Fractures in Adults with Hypophosphatasia
por: Rassie, Kate, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2g2a179ndkt5i91vdnnib77had